477 related articles for article (PubMed ID: 22513064)
1. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.
Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J
J Cutan Med Surg; 2012; 16(2):115-21. PubMed ID: 22513064
[TBL] [Abstract][Full Text] [Related]
2. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.
Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J
J Cutan Med Surg; 2012; 16(5):317-23. PubMed ID: 22971306
[TBL] [Abstract][Full Text] [Related]
3. Oral propranolol: an effective, safe treatment for infantile hemangiomas.
Zaher H; Rasheed H; Hegazy RA; Hegazy RA; Abdelhalim DM; Gawdat HI
Eur J Dermatol; 2011; 21(4):558-63. PubMed ID: 21697036
[TBL] [Abstract][Full Text] [Related]
4. Propranolol for treatment of ulcerated infantile hemangiomas.
Saint-Jean M; Léauté-Labrèze C; Mazereeuw-Hautier J; Bodak N; Hamel-Teillac D; Kupfer-Bessaguet I; Lacour JP; Naouri M; Vabres P; Hadj-Rabia S; Nguyen JM; Stalder JF; Barbarot S;
J Am Acad Dermatol; 2011 May; 64(5):827-32. PubMed ID: 21353332
[TBL] [Abstract][Full Text] [Related]
5. Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center.
Buckmiller LM; Munson PD; Dyamenahalli U; Dai Y; Richter GT
Laryngoscope; 2010 Apr; 120(4):676-81. PubMed ID: 20112413
[TBL] [Abstract][Full Text] [Related]
6. Propranolol treatment for infantile hemangioma: a case series of sixty-two patients.
Stringari G; Barbato G; Zanzucchi M; Marchesi M; Cerasoli G; Tchana B; Gritti A; Boccaletti V; Lombardi AA; Carano N
Pediatr Med Chir; 2016 Jun; 38(2):113. PubMed ID: 27345601
[TBL] [Abstract][Full Text] [Related]
7. Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study.
Zvulunov A; McCuaig C; Frieden IJ; Mancini AJ; Puttgen KB; Dohil M; Fischer G; Powell J; Cohen B; Ben Amitai D
Pediatr Dermatol; 2011; 28(2):94-8. PubMed ID: 21362031
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of propranolol in the treatment of infantile hemangioma beyond the proliferation phase.
Vivas-Colmenares GV; Bernabeu-Wittel J; Alonso-Arroyo V; Matute de Cardenas JA; Fernandez-Pineda I
Pediatr Dermatol; 2015; 32(3):348-52. PubMed ID: 25721095
[TBL] [Abstract][Full Text] [Related]
9. Treatment of problematic infantile hemangiomas with propranolol: a series of 40 cases and review of the literature.
Oksiuta M; Matuszczak E; Dębek W; Dzienis-Koronkiewicz E; Hermanowicz A; Tylicka M
Postepy Hig Med Dosw (Online); 2014 Sep; 68():1138-44. PubMed ID: 25228522
[TBL] [Abstract][Full Text] [Related]
10. Use of propranolol for the treatment infantile hemangiomas in the maxillofacial region.
Sadykov RR; Podmelle F; Sadykov RA; Kasimova KR; Metellmann HR
Int J Oral Maxillofac Surg; 2013 Jul; 42(7):863-7. PubMed ID: 23618833
[TBL] [Abstract][Full Text] [Related]
11. Propranolol for infantile hemangiomas.
Bagazgoitia L; Torrelo A; Gutiérrez JC; Hernández-Martín A; Luna P; Gutiérrez M; Baño A; Tamariz A; Larralde M; Alvarez R; Pardo N; Baselga E
Pediatr Dermatol; 2011; 28(2):108-14. PubMed ID: 21385205
[TBL] [Abstract][Full Text] [Related]
12. [Chinese experts consensus on the use of oral propranolol for treatment of infantile hemangiomas].
Zheng JW; Wang XK; Qin ZP; Fan XD; Li K; Yang YW; Huo R; Liu SH; Zhao JH; Wang XY; Zhou DK
Shanghai Kou Qiang Yi Xue; 2016 Jun; 25(3):257-60. PubMed ID: 27609372
[TBL] [Abstract][Full Text] [Related]
13. Late rebound of infantile hemangioma after cessation of oral propranolol.
Shehata N; Powell J; Dubois J; Hatami A; Rousseau E; Ondrejchak S; McCuaig C
Pediatr Dermatol; 2013; 30(5):587-91. PubMed ID: 24016283
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the effectiveness of topical propranolol 4% gel for infantile hemangiomas.
Mashiah J; Kutz A; Rabia SH; Ilan EB; Goldberg I; Sprecher E; Harel A
Int J Dermatol; 2017 Feb; 56(2):148-153. PubMed ID: 28074521
[TBL] [Abstract][Full Text] [Related]
15. Propranolol treatment for severe infantile hemangiomas: a single-centre 3-year experience.
Georgountzou A; Karavitakis E; Klimentopoulou A; Xaidara A; Kakourou T
Acta Paediatr; 2012 Oct; 101(10):e469-74. PubMed ID: 22804809
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and management of infantile hemangiomas.
Püttgen KB
Pediatr Clin North Am; 2014 Apr; 61(2):383-402. PubMed ID: 24636652
[TBL] [Abstract][Full Text] [Related]
17. Low-dose propranolol regimen for infantile haemangioma.
Tan CE; Itinteang T; Leadbitter P; Marsh R; Tan ST
J Paediatr Child Health; 2015 Apr; 51(4):419-24. PubMed ID: 25187156
[TBL] [Abstract][Full Text] [Related]
18. Treatment for Infantile Hemangiomas: Selection Criteria, Safety, and Outcomes Using Oral Propranolol During the Early Phase of Propranolol Use for Hemangiomas.
MacIsaac ZM; Nayar HS; Gehris R; Mehta D; Geisler S; Grunwaldt LJ
J Craniofac Surg; 2016 Jan; 27(1):159-62. PubMed ID: 26674892
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound in assessing the efficacy of propranolol therapy for infantile hemangiomas.
Shi H; Song H; Wang J; Xia L; Yang J; Shang Y; Zhou H
Ultrasound Med Biol; 2014 Nov; 40(11):2622-9. PubMed ID: 25220276
[TBL] [Abstract][Full Text] [Related]
20. Topical propranolol therapy for infantile hemangiomas.
Kunzi-Rapp K
Pediatr Dermatol; 2012; 29(2):154-9. PubMed ID: 22141326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
